{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:30:40Z","timestamp":1792506640131,"version":"4.5.0"},"reference-count":34,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2967\/jnumed.122.264775","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:25:25Z","timestamp":1675373125000},"page":"885-891","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Safety of<sup>124<\/sup>I-MIBG Dosimetry-Guided High-Activity<sup>131<\/sup>I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma"],"prefix":"10.2967","volume":"64","author":[{"given":"Ines","family":"Maric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Prochnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt M.","family":"Schaarschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten D.","family":"Poeppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Rischpler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bockisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Jentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"2023060112150619000_64.6.885.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2011.05.003"},{"key":"2023060112150619000_64.6.885.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.243139"},{"key":"2023060112150619000_64.6.885.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262797"},{"key":"2023060112150619000_64.6.885.4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00259-016-3516-0","article-title":"123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel","volume":"44","author":"Lewington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023060112150619000_64.6.885.5","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)00509-4"},{"key":"2023060112150619000_64.6.885.6","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.118.225409","article-title":"Preclinical pharmacokinetics and dosimetry studies of 124I\/131I-CLR1404 for treatment of pediatric solid tumors in murine xenograft models","volume":"60","author":"Marsh","year":"2019","journal-title":"J Nucl Med."},{"key":"2023060112150619000_64.6.885.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00612-8"},{"key":"2023060112150619000_64.6.885.8","doi-asserted-by":"publisher","DOI":"10.4111\/kju.2011.52.4.241"},{"key":"2023060112150619000_64.6.885.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.06.010"},{"key":"2023060112150619000_64.6.885.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.217463"},{"key":"2023060112150619000_64.6.885.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.064469"},{"key":"2023060112150619000_64.6.885.12","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2007.301"},{"key":"2023060112150619000_64.6.885.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0715-3"},{"key":"2023060112150619000_64.6.885.14","first-page":"21","article-title":"Quantitative imaging of (124)I with PET\/CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections","volume":"55","author":"Jentzen","year":"2011","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2023060112150619000_64.6.885.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.153031"},{"key":"2023060112150619000_64.6.885.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.144089"},{"key":"2023060112150619000_64.6.885.17","first-page":"121","article-title":"124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact","volume":"46","author":"Freudenberg","year":"2007","journal-title":"Nucl Med (Stuttg)."},{"key":"2023060112150619000_64.6.885.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0554-7"},{"key":"2023060112150619000_64.6.885.19","first-page":"108","article-title":"Segmentation of PET volumes by iterative image thresholding","volume":"48","author":"Jentzen","year":"2007","journal-title":"J Nucl Med."},{"key":"2023060112150619000_64.6.885.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.114.152678"},{"key":"2023060112150619000_64.6.885.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1351-2"},{"key":"2023060112150619000_64.6.885.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3496"},{"key":"2023060112150619000_64.6.885.23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s12149-020-01514-2","article-title":"High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience","volume":"34","author":"Wakabayashi","year":"2020","journal-title":"Ann Nucl Med."},{"key":"2023060112150619000_64.6.885.24","first-page":"576","article-title":"Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases","volume":"26","author":"Shapiro","year":"1985","journal-title":"J Nucl Med."},{"key":"2023060112150619000_64.6.885.25","doi-asserted-by":"publisher","DOI":"10.1118\/1.3480965"},{"key":"2023060112150619000_64.6.885.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.047159"},{"key":"2023060112150619000_64.6.885.27","first-page":"143","article-title":"Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software","volume":"48","author":"Kolbert","year":"2007","journal-title":"J Nucl Med."},{"key":"2023060112150619000_64.6.885.28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MNM.0000000000000817","article-title":"Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activities","volume":"39","author":"Ruhlmann","year":"2018","journal-title":"Nucl Med Commun."},{"key":"2023060112150619000_64.6.885.29","doi-asserted-by":"crossref","first-page":"20170969","DOI":"10.1259\/bjr.20170969","article-title":"Theranostic radiopharmaceuticals: established agents in current use","volume":"91","author":"Ballinger","year":"2018","journal-title":"Br J Radiol."},{"key":"2023060112150619000_64.6.885.30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fmed.2020.00173","article-title":"MIBG therapy for neuroblastoma: precision achieved with dosimetry, and concern for false responders","volume":"7","author":"Rubio","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"2023060112150619000_64.6.885.31","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200307000-00009"},{"key":"2023060112150619000_64.6.885.32","first-page":"1132","article-title":"Radioiodine-131 therapy for well-differentiated thyroid cancer\u2014a quantitative radiation dosimetric approach: outcome and validation in 85 patients","volume":"33","author":"Maxon","year":"1992","journal-title":"J Nucl Med."},{"key":"2023060112150619000_64.6.885.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.170571"},{"key":"2023060112150619000_64.6.885.34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.168799"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.264775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:17:38Z","timestamp":1685647058000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.264775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,1]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2967\/jnumed.122.264775"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.264775","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}